| Mark R Connell, MD | |
|
1613 N Mckenzie St, Foley, AL 36535-2247 | |
| (251) 476-5443 | |
| (251) 476-0116 |
| Full Name | Mark R Connell |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 1613 N Mckenzie St, Foley, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730146069 | NPI | - | NPPES |
| 009936421 | Medicaid | AL | |
| 51003532 | Other | AL | BC MONTCLAIR |
| 009936423 | Medicaid | AL | |
| 51003530 | Other | AL | BC GREYSTONE |
| 51003540 | Other | AL | BC SYLACAUGA |
| 51003538 | Other | AL | BC SHELBY |
| 009936422 | Medicaid | AL | |
| 009936426 | Medicaid | AL | |
| 009936424 | Medicaid | AL | |
| 51003539 | Other | AL | BC 280 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 24737 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Baldwin Regional Medical Center | Foley, AL | Hospital |
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Baldwin Diagnostic Imaging Associates, P.c. | 1254380769 | 4 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced it treated its first patients in a phase I study of Debio 1143 combined with Carboplatin and Paclitaxel in patients with squamous non-small cell lung cancer, platinum-refractory ovarian cancer, and basal-like/claudin low triple negative breast cancer.
U.N. agencies have begun providing humanitarian assistance in the western region of Libya for the first time since civil unrest began in February, following an April 17 agreement between the organization and the Libyan government to allow a "humanitarian corridor," Bloomberg reports (Varner, 4/19).
The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."
Results from an international multi-center Phase II clinical trial suggest that extracorporeal photopheresis (ECP) may be effective in treating patients with clinically active (OR symptomatic) Crohn?s disease who cannot tolerate or are refractory to immunosuppressants and/or anti-TNF agents.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
› Verified 6 days ago
| Entity Name | South Baldwin Diagnostic Imaging Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124000856 PECOS PAC ID: 1254380769 Enrollment ID: O20050121000219 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced it treated its first patients in a phase I study of Debio 1143 combined with Carboplatin and Paclitaxel in patients with squamous non-small cell lung cancer, platinum-refractory ovarian cancer, and basal-like/claudin low triple negative breast cancer.
U.N. agencies have begun providing humanitarian assistance in the western region of Libya for the first time since civil unrest began in February, following an April 17 agreement between the organization and the Libyan government to allow a "humanitarian corridor," Bloomberg reports (Varner, 4/19).
The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."
Results from an international multi-center Phase II clinical trial suggest that extracorporeal photopheresis (ECP) may be effective in treating patients with clinically active (OR symptomatic) Crohn?s disease who cannot tolerate or are refractory to immunosuppressants and/or anti-TNF agents.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark R Connell, MD Po Box 7866, Mobile, AL 36670-0866 Ph: (251) 476-5443 | Mark R Connell, MD 1613 N Mckenzie St, Foley, AL 36535-2247 Ph: (251) 476-5443 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced it treated its first patients in a phase I study of Debio 1143 combined with Carboplatin and Paclitaxel in patients with squamous non-small cell lung cancer, platinum-refractory ovarian cancer, and basal-like/claudin low triple negative breast cancer.
U.N. agencies have begun providing humanitarian assistance in the western region of Libya for the first time since civil unrest began in February, following an April 17 agreement between the organization and the Libyan government to allow a "humanitarian corridor," Bloomberg reports (Varner, 4/19).
The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."
Results from an international multi-center Phase II clinical trial suggest that extracorporeal photopheresis (ECP) may be effective in treating patients with clinically active (OR symptomatic) Crohn?s disease who cannot tolerate or are refractory to immunosuppressants and/or anti-TNF agents.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
› Verified 6 days ago
Dr. John J Campbell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1613 N Mckenzie St, Foley, AL 36535 Phone: 251-949-1513 Fax: 251-621-4837 | |
Dr. Ralph H Ewing Jr., M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1613 N Mckenzie St, Foley, AL 36535 Phone: 251-949-3513 Fax: 251-476-5460 | |
Dr. Jason Russell Williams, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 111 W Myrtle Ave, Suite 1, Foley, AL 36535 Phone: 251-943-9409 Fax: 251-943-9724 | |
Dr. William P Jones, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1613 N Mckenzie St, Foley, AL 36535 Phone: 251-949-1513 Fax: 251-476-5460 |